Published in AIDS Weekly, November 25th, 2002
The senior management includes Peter McCann, PhD, president and CEO; Joseph Mosca, PhD, vice president, development; and Pierre-Francois Serres, PhD, vice president, research and founder.
Most recently, McCann was president and CEO of Oncostasis, Inc., a genomics-based cancer therapeutics company. He is also the former president of the University of Maryland's Biotechnology Institute, and of British Biotech, Inc.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.